Clinical Trials Logo

Clinical Trial Summary

This is a Phase I trial to evaluate Pharmacokinetics, Pharmacodynamics and Safety of Isosorbide Mononitrate gel for usage in participants with anal fissure and healthy volunteers. Three doses will be used in patients with anal fissure (0.5%, 1.0% or 2.0%) and healthy volunteers will receive 2.0% dose. All treatment will last 7 days.


Clinical Trial Description

This is a Phase I, open-label, parallel trial to evaluate Pharmacokinetics, Pharmacodynamics and Safety of Isosorbide Mononitrate gel for usage in participants with anal fissure and healthy volunteers.

Investigational product will be randomly assigned as follows:

- healthy volunteers will receive 2g (2.0%) of investigational product at a single dose, and will undergo a washout period of 7 days; subsequently, they will receive 2g of investigational product once daily, for 7 consecutive days;

- participants with anal fissure will receive 2g of investigational product, either at 0.5%, 1.0% or 2.0%, at a single dose, and will undergo a washout period of 7 days; subsequently, they will receive 2g of investigational product, either at 0.5%, 1.0% or 2.0%, once daily, for 7 consecutive days. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT02667535
Study type Interventional
Source Biolab Sanus Farmaceutica
Contact
Status Withdrawn
Phase Phase 1
Start date July 2017
Completion date November 2017

See also
  Status Clinical Trial Phase
Completed NCT06216223 - Laser Versus Surgery in Anal Diseases in Inflammatory Bowel Patients N/A
Not yet recruiting NCT05405634 - Microbiota in Chronic Anal Fissure and Its Association With Prognosis
Completed NCT05736926 - Anal Fissure Among Survivors of COVID-19 Virus Infection.
Enrolling by invitation NCT00980369 - The Importance of Lateral Internal Sphincterotomy Incision: Parallel or Vertical N/A
Completed NCT05616455 - Efficacy and Safety of Propionibacterium Extract Gel Versus 0.4% Glyceryl Trinitrate Ointment in the Treatment of Chronic Anal Fissure: a Randomised Controlled Trial Phase 4
Completed NCT04173130 - Monocentric Feasibility Study for a New Medical Device for the Treatment of Anal Fissure With Botulinum Toxin N/A
Completed NCT03345511 - Ultrasound Guided Caudal Block for Benign Anal Surgery N/A
Completed NCT05341180 - Efficacy of Polyethylene Glycol vs Lactulose With Isabgol in Acute Fissure-in-Ano: PEGASIS Trial Phase 2/Phase 3
Completed NCT03528772 - Topical Minoxidil Versus Topical Glyceryl Trinitrate in Treatment of Chronic Anal Fissure N/A
Active, not recruiting NCT04428697 - Sungurtekin Technique vs. Closed Lateral Internal Sphincterotomy Technique N/A
Terminated NCT02023047 - An Open Label Multi-Dose Study to Examine the Effect of Coated Nifedipine Suppository on Anal Fissure Pain and Healing Phase 1/Phase 2
Withdrawn NCT01920074 - Pharmacokinetic,Safety and Exploratory Efficacy of RECTIV® in Adolescents With Chronic Anal Fissure Phase 4
Recruiting NCT01039051 - Diet and Lifestyle Intervention Study in Postpartum Women in China Phase 2/Phase 3
Completed NCT00210444 - Efficacy Study of Dysport® in the Treatment of Anal Fissure. Phase 2
Completed NCT00827736 - Comparison of Treatment Success of Botox Injection in the Internal Sphincter Versus Isosorbidedinitrate Ointment in Patients With an Anal Fissure Phase 4
Not yet recruiting NCT06049524 - Could Preoperative Assessment of Physical and Psychological Status Help Predict Pain After Anorectal Surgery?
Not yet recruiting NCT05709717 - Regenerative Therapy With Autologous Stromal Vascular Fraction Derived Mesenchymal Stem Cells and Platelet-rich Plasma to Treat Complex Perianal Diseases
Completed NCT05038605 - Topical vs Oral Metronidazole After Benign Anorectal Surgery N/A
Not yet recruiting NCT03780998 - Effects of Sodium Pentaborat Based Gel on Perianal Benign Diseases
Completed NCT03426449 - Posterolateral Versus Lateral Internal Anal Sphincterotomy for Chronic Anal Fissure N/A